Target intelligence / Profile preview

Influenza A hemagglutinin stalk domain (HA-stalk (not a universal standard, but commonly used in scientific literature for the stalk domain of hemagglutinin))

Target
HA-stalk (not a universal standard, but commonly used in scientific literature for the stalk domain of hemagglutinin)
Molecular classification
Viral surface glycoprotein domain, Fusion protein domain, Class I fusion protein subunit
01

Overview

The **Influenza A hemagglutinin stalk domain** is a highly conserved, membrane-proximal region of the hemagglutinin (HA) surface glycoprotein of the influenza A virus. Hemagglutinin is a trimeric protein that mediates viral attachment and entry into host cells. Each monomer consists of two subunits, HA1 and HA2, generated by proteolytic cleavage. The stalk domain is primarily composed of the C- and N-terminal regions of the HA1 subunit and the majority of the HA2 subunit. In contrast to the variable globular head (receptor-binding) domain, the stalk domain is highly conserved across different influenza A subtypes, largely due to its essential role in mediating the pH-triggered fusion between viral and endosomal membranes, which is necessary for viral genome release into the host cell. Antibodies that target this domain can neutralize a broad spectrum of influenza A viruses and are a focus for the development of universal influenza vaccines and therapeutic antibodies. The stalk domain is considered a structural target for broad, cross-strain protection because its function limits its ability to tolerate mutations without loss of viral fitness. Detection of anti-HA stalk antibodies is used in research as a biomarker for broadly protective immunity. Currently, there are no drugs approved that target this domain directly, but several monoclonal antibodies are under investigation.

Other names
Hemagglutinin stem domainHA stemHA stalkStalk domain of influenza A hemagglutinin
02

Mechanism of action

Broadly neutralizing antibodies bind to conserved epitopes in the stalk domain, inhibiting the fusion step of viral entry and thus blocking infection. These antibodies can mediate antibody-dependent cellular cytotoxicity (ADCC) and complement activation to clear infected cells.

03

Biological functions

Mediates membrane fusion between viral envelope and host endosomal membraneEnables viral genome release into host cell cytosolActs as a major epitope for broadly neutralizing antibodies
04

Disease associations

Infection (Influenza A)Target for pandemic and seasonal influenza infection interventions
05

Safety considerations

Potential for viral escape if universal vaccines are widely deployed, although the stalk domain is relatively intolerant to mutationOff-target immune reactions not currently reported as a recurring safety issue for stalk-specific antibodies
06

Interacting drugs

CR6261

2 more in the full profile.

07

Biomarkers

Presence of anti-HA stalk antibodies in serum is a biomarker of cross-protective immunity against diverse Influenza A strainsHA-stalk-specific antibody titers are used in evaluating vaccine responses in research settings

Beyond the preview

Go deeper on Influenza A hemagglutinin stalk domain (HA-stalk (not a universal standard, but commonly used in scientific literature for the stalk domain of hemagglutinin)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza A hemagglutinin stalk domain (HA-stalk (not a universal standard, but commonly used in scientific literature for the stalk domain of hemagglutinin)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call